At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 318 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Amoxicillin and clavulanic acid 125 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Situations That do Not Require Antibiotics for Acute Exacerbations of Mild-to-moderate Chronic Obstructive Pulmonary Disease
Societat Catalana de Medicina Familiar i Comunitària, Assoc. (CAMFiC)·interventional·Posted Jul 3, 2007·Updated Mar 13, 2012
In Brief
A Phase 4 clinical trial evaluating Placebo and Amoxicillin and clavulanic acid for Chronic Obstructive Pulmonary Disease. Completed, enrolled 318 participants across 13 sites.
Detailed Summary
The purpose of this study is to determine the effectiveness of antibiotic therapy for patients with acute exacerbations of mild-to-moderate chronic obstructive pulmonary disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Obstructive Pulmonary Disease
CountriesSpain
CollaboratorsFondo de Investigacion Sanitaria
Timeline
Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 2007
Enrollment StartOct 2007
Primary CompletionJul 2010
Study CompletionJul 2011
TodayJul 2026
First PostedJul 3, 2007
Enrollment StartOct 1, 2007
Primary CompletionJul 1, 2010
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 19.0 years ago
Interventions
Placebodrug
One pill to be taken every eight hours for 8 days
Amoxicillin and clavulanic aciddrug
500-125 mg to be taken every eight hours for 8 days